Aperio Group LLC lowered its stake in shares of Envision Healthcare Corporation (NYSE:EVHC) by 5.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,627 shares of the company’s stock after selling 1,414 shares during the period. Aperio Group LLC’s holdings in Envision Healthcare Corporation were worth $1,152,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Exane Derivatives bought a new stake in shares of Envision Healthcare Corporation during the 3rd quarter worth approximately $475,000. Schwab Charles Investment Management Inc. raised its stake in shares of Envision Healthcare Corporation by 5.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 632,195 shares of the company’s stock worth $39,620,000 after purchasing an additional 33,587 shares in the last quarter. Nomura Holdings Inc. bought a new stake in shares of Envision Healthcare Corporation during the 2nd quarter worth approximately $797,000. Maverick Capital Ltd. raised its stake in shares of Envision Healthcare Corporation by 66.2% during the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after purchasing an additional 2,028,026 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its stake in shares of Envision Healthcare Corporation by 17.2% during the 3rd quarter. Mutual of America Capital Management LLC now owns 87,025 shares of the company’s stock worth $3,912,000 after purchasing an additional 12,768 shares in the last quarter.

Envision Healthcare Corporation (NYSE EVHC) opened at $29.05 on Friday. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. Envision Healthcare Corporation has a 1-year low of $23.77 and a 1-year high of $74.75. The company has a market capitalization of $3,511.83, a price-to-earnings ratio of 8.97, a price-to-earnings-growth ratio of 0.75 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same period in the prior year, the company earned $1.13 earnings per share. The business’s quarterly revenue was up 142.0% compared to the same quarter last year. equities research analysts predict that Envision Healthcare Corporation will post 2.57 earnings per share for the current year.

Envision Healthcare Corporation declared that its Board of Directors has approved a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

A number of research analysts recently weighed in on the company. Mizuho decreased their target price on Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating on the stock in a report on Wednesday, August 9th. Citigroup Inc. lowered Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $31.00 target price on the stock. in a report on Thursday, November 2nd. BidaskClub lowered Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Bank of America Corporation decreased their target price on Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, October 9th. Finally, Canaccord Genuity reissued a “buy” rating and set a $32.00 target price (down from $68.00) on shares of Envision Healthcare Corporation in a report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Envision Healthcare Corporation currently has an average rating of “Buy” and a consensus price target of $47.57.

COPYRIGHT VIOLATION WARNING: “Aperio Group LLC Has $1.15 Million Stake in Envision Healthcare Corporation (EVHC)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/19/aperio-group-llc-has-1-15-million-stake-in-envision-healthcare-corporation-evhc.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.